Protection from obesity and insulin resistance in mice overexpressing human apolipoprotein C1

Diabetes

Volumn 50, Issue 12, 2001, Pages 2779-2785

  Jong, Miek C ^a   Voshol, Peter J ^a,b   Muurling, Martin ^a   Dahlmans, Vivian E H ^a   Romijn, Johannes A ^b   Pijl, Hanno ^b   Havekes, Louis M ^a,b  

^a TNO   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

15 (4 IODOPHENYL) 3 METHYLPENTADECANOIC ACID; 15-(4-IODOPHENYL)-3-METHYLPENTADECANOIC ACID; APOLIPOPROTEIN C; APOLIPOPROTEIN C I; APOLIPOPROTEIN C-I; CHOLESTEROL; FATTY ACID; INSULIN; IODOBENZENE; RADIOACTIVE IODINE; TRIACYLGLYCEROL;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL; ARTICLE; BLOOD; CELL SIZE; CROSS BREEDING; GENE EXPRESSION; GENETICS; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HUMAN; INSULIN RESISTANCE; MALE; METABOLISM; MOUSE; MOUSE MUTANT; OBESITY; ORGAN WEIGHT; PATHOLOGY; PHYSIOLOGY; TRANSGENIC MOUSE; WEIGHT REDUCTION;

ADIPOCYTES; ADIPOSE TISSUE; ANIMAL; APOLIPOPROTEINS C; BLOOD GLUCOSE; CELL SIZE; CHOLESTEROL; CROSSES, GENETIC; FATTY ACIDS; FATTY ACIDS, NONESTERIFIED; GENE EXPRESSION; GLUCOSE TOLERANCE TEST; HUMAN; INSULIN; INSULIN RESISTANCE; IODINE RADIOISOTOPES; IODOBENZENES; MALE; MICE; MICE, OBESE; MICE, TRANSGENIC; OBESITY; ORGAN WEIGHT; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TRIGLYCERIDES; WEIGHT LOSS;

EID: 0035650636     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.50.12.2779     Document Type: Article

References (26)

1. Lauer SJ, Walker D, Elshourbagy NA, Reardon CA, Levy-Wilson B, Taylor JM: Two copies of the human apolipoprotein C-I gene are linked closely to the apolipoprotein E gene. J Biol Chem 263:7277-7286, 1988
2. Shulman RS, Herbert PN, Wehrly K, Fredrickson DS: Thf complete amino acid sequence of C-I (apoLp-Ser), an apolipoprotein from human very low density lipoproteins. J Biol Chem 250:182-190, 1975
3. Jong MC, Dahlmans VE, van Gorp PJ, van Dijk KW, Breuer ML, Hofker MH, Havekes LM: In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway. J Clin Invest 98:2259-2267, 1996
4. Shachter NS, Ebara T, Ramakrishnan R, Steiner G, Breslow JL, Ginsberg HN, Smith JD: Combined hyperlipidemia in transgenic mice overexpressing human apolipoprotein C1. J Clin Invest 98:846-855, 1996
5. Jong MC, Gijbels MJ, Dahlmans VE, Gorp PJ, Koopman SJ, Ponec M, Hofker MH, Havekes LM: Hyperlipidemia and cutaneous abnormalities in transgenic mice overexpressing human apolipoprotein C1. J Clin Invest 101:145-152, 1998
6. Koopmans SJ, Jong MC, Que I, Dahlmans VEH, Pijl H, Radder JK, Frolich M, Havekes LM: Hyperlipidemia is associated with increased insulin-mediated glucose metabolism, reduced fatty acid metabolism and normal blood pressure in transgenic mice overexpressing human apolipoprotein C1. Diabetologia 44:437-443, 2001
7. Mertens J, Eersels J, Vanryckeghem W: New high yield Cu(T) assisted 1231 radioiodination of 15(p-I-phenyl)-9-methyl pentadecanoic acid, a potential myocardial tracer. Eur J Nucl Med 13:159-160, 1987
8. Minich DM, Kalivianakis M, Havinga R, van Goor H, Stellaard F, Vonk RJ, Kuipers F, Verkade HJ: Bile diversion in rats leads to a decreased plasma concentration of linoleic acid which is not due to decreased net intestinal absorption of dietary linoleic acid. Biochim Biophys Acta 1438:111-119, 1999
9. Coburn CT, Knapp FF, Febbraio M, Beets AL, Silverstein RL, Abumrad NA: Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knockout mice. J Biol Chem 275:32523-32529, 2000
10. Zambon A, Hashimoto SI, Brunzell JD: Analysis of techniques to obtain plasma for measurement of levels of free fatty acids. J Lipid Res 34:1021-1028, 1993
11. Dawson-Saunders B, Trapp RG: Basic and Clinical Biostatistics. London, Appleton & Lange, 2001
12. DeFronzo RA, Ferrannini E: Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14:173-194, 1991
13. Murase T, Mizuno T, Omachi T, Onizawa K, Komine Y, Kondo H, Hase T, Tokimitsu I: Dietary diacylglycerol suppresses high fat and high sucrose diet-induced body fat accumulation in C57BL/6J mice. J Lipid Res 42:372-378, 2001
14. Ceddia RB, William WN, Curi R: The response of skeletal muscle to leptin. Front Biosci 6:D90-D97, 2001
15. Kiess W, Siebler T, Englaro P, Kratzsch J, Deutscher J, Meyer K, Gallaher B, Blum WF: Leptin as a metabolic regulator during fetal and neonatal life and in childhood and adolescence. J Pediatr Endocrinol Metab 11:483-496, 1998
16. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, Collins F: Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269:540-543, 1995
17. Smith SJ, Cases S, Jensen DR, Chen HC, Sande E, Tow B, Sanan DA, Raber J, Eckel RH, Farese RVJ: Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat. Nat Genet 25:87-90, 2000
18. Boden G: Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 46:3-10, 1997
19. Reaven GM, Hollenbeck C, Jeng CY, Wu MS, Chen YD: Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM. Diabetes 37:1020-1024, 1988
20. Boden G, Chen X: Effects of fat on glucose uptake and utilization in patients with non-insulin-dependent diabetes. J Clin Invest 96:1261-1268, 1995
21. Lewis GF: Fatty acid regulation of very low density lipoprotein production. Curr Opin Lipidol 8:146-153, 1997
22. Reaven GM, Mondon CE, Chen YD, Breslow JL: Hypertriglyceridemic mice transgenic for the human apolipoprotein C-III gene are neither insulin resistant nor hyperinsulinemic. J Lipid Res 35:820-824, 1994
23. Ebara T, Ramakrishnan R, Steiner G, Shachter NS: Chylomicronemia due to apolipoprotein CIII overexpression in apolipoprotein E-null mice: apolipoprotein CIII-induced hypertriglyceridemia is not mediated by effects on apolipoprotein E. J Clin Invest 99:2672-2681, 1997
24. Randle PJ, Garland PB, Newsholme EA, Hales CN: The glucose fatty acid cycle in obesity and maturity onset diabetes mellitus. Ann N Y Acad Sci 131:324-333, 1965
25. Garland PB, Randle PJ: Regulation of glucose uptake by muscles. 10. Effects of alloxan-diabetes, starvation, hypophysectomy and adrenalectomy, and of fatty acids, ketone bodies and pyruvate, on the glycerol output and concentrations of free fatty acids, long-chain fatty acylcoenzyme A, glycerol phosphate and citrate-cycle intermediates in rat heart and diaphragm muscles. Biochem J 93:678-687, 1964
26. Hultin M, Savonen R, Olivecrona T: Chylomicron metabolism in rats: lipolysis, recirculation of triglyceride-derived fatty acids in plasma FFA, and fate of core lipids as analyzed by compartmental modelling. J Lipid Res 37:1022-1036, 1996